Humana Inc. (NYSE:HUM) Stake Raised by Davis Selected Advisers

Key Points

• Davis Selected Advisers increased its stake in Humana Inc. by 3.3%, acquiring an additional 74,434 shares, which now makes up about 3.6% of its portfolio.
• Humana's stock has received mixed analyst ratings, with price targets ranging from $260 to $348, and a consensus rating of "Hold".
• The company reported earnings of $6.27 per share for the last quarter, missing the consensus estimate by $0.05, although revenue increased 9.6% year-over-year.

Davis Selected Advisers grew its stake in Humana Inc. (NYSE:HUM - Free Report) by 3.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,331,343 shares of the insurance provider's stock after purchasing an additional 74,434 shares during the quarter. Humana makes up 3.6% of Davis Selected Advisers' holdings, making the stock its 10th biggest position. Davis Selected Advisers owned about 1.93% of Humana worth $616,873,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors have also modified their holdings of the stock. Cary Street Partners Investment Advisory LLC grew its position in shares of Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock valued at $31,000 after purchasing an additional 46 shares during the period. Applied Finance Capital Management LLC boosted its position in Humana by 1.7% during the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock worth $779,000 after acquiring an additional 48 shares during the last quarter. Achmea Investment Management B.V. boosted its position in Humana by 0.5% during the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock worth $2,746,000 after acquiring an additional 49 shares during the last quarter. Beech Hill Advisors Inc. boosted its position in Humana by 6.1% during the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock worth $229,000 after acquiring an additional 50 shares during the last quarter. Finally, Deseret Mutual Benefit Administrators boosted its position in Humana by 15.8% during the first quarter. Deseret Mutual Benefit Administrators now owns 462 shares of the insurance provider's stock worth $122,000 after acquiring an additional 63 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Wells Fargo & Company set a $348.00 price target on shares of Humana in a research report on Friday, July 18th. Bank of America lowered their price target on shares of Humana from $320.00 to $260.00 and set a "neutral" rating on the stock in a research report on Tuesday, June 17th. Robert W. Baird lowered their price target on shares of Humana from $300.00 to $297.00 and set a "neutral" rating on the stock in a research report on Friday, July 25th. Truist Financial lowered their price target on shares of Humana from $280.00 to $260.00 and set a "hold" rating on the stock in a research report on Wednesday, July 16th. Finally, Piper Sandler lowered their price target on shares of Humana from $288.00 to $272.00 and set a "neutral" rating on the stock in a research report on Thursday, July 31st. Seventeen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, Humana presently has an average rating of "Hold" and an average price target of $281.62.

Humana Trading Up 4.1%

Shares of HUM stock traded up $10.51 during trading hours on Friday, hitting $266.65. The company had a trading volume of 1,678,249 shares, compared to its average volume of 1,999,296. The company's fifty day moving average is $237.88 and its 200 day moving average is $254.16. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $382.72. The stock has a market capitalization of $32.07 billion, a PE ratio of 20.46, a price-to-earnings-growth ratio of 1.57 and a beta of 0.44.

Humana (NYSE:HUM - Get Free Report) last announced its earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing the consensus estimate of $6.32 by ($0.05). Humana had a return on equity of 13.67% and a net margin of 1.28%. The business had revenue of $32.39 billion for the quarter, compared to analysts' expectations of $31.85 billion. During the same period in the previous year, the company earned $6.96 earnings per share. Humana's quarterly revenue was up 9.6% on a year-over-year basis. Research analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.